Market Overview:
The global feed nucleotides market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in the market can be attributed to the increasing demand for feed additives and supplements, especially in developed countries. Feed nucleotides are used as dietary supplements and immune enhancers in livestock and poultry farming, which is driving their demand. Additionally, the growing awareness about the benefits of feed nucleotides is also contributing to their growth. On the basis of type, yeast/yeast extracts accounted for a major share of the global feed nucleotides market in 2017. This can be attributed to their high nutritional value and easy availability.
Product Definition:
Feed Nucleotides are a specific type of nucleotide that is found in the feed of animals and plants. They are important for the growth and development of these organisms, as well as their overall health. Feed nucleotides can be used to improve the quality of livestock feed, as well as increase the yield and quality of crops.
Yeast/Yeast Extracts:
Yeast/ yeast extracts are the by-products obtained during the fermentation of yeasts. The most commonly used type of yeast extract is sodium salt (sodium yeast) which has a high content of protein and amino acids. It also contains vitamins, minerals, and other nutrients necessary for cell growth.
Single Cell Organisms:
Single Cell Organisms (SCO) are also known as Micro-Organisms or Nanobacteria. They are very small biological particles, which consist of one or more cells. These organisms have applications in the feed nucleotides market for improving animal health and performance by enhancing immune function, counteracting pathogens & parasites and increasing resistance to disease.
Application Insights:
The immune enhancers segment held the largest market share in 2017 and is expected to witness significant growth over the forecast period. Feed nucleotides are widely used in poultry diets for enhancing immunity against infectious diseases, cancer, and allergies. The growing prevalence of chronic diseases such as cancer, diabetes mellitus, and autoimmune disorders among livestock animals has led to increased demand for feed additives that enhance animal health.
Dietary supplements are intended for humans who eat meat or animal products but cannot obtain sufficient amounts of certain nutrients from a normal diet. These include vitamin B12 (cobalamin), folic acid (folate), iron zinc copper salts (cuprum arsenic calcium carbonate), choline bitartrate/choline chloride/caffeine anhydrous/sodium bicarbonate (all found naturally in eggs) among others.
Regional Analysis:
North America dominated the global feed nucleotides market in 2017. The growth of this region can be attributed to the presence of a large number of feed manufacturers and suppliers coupled with high demand for animal-based products. In addition, increasing prevalence of chronic diseases in North America is expected to drive the demand for immune enhancers over the forecast period.
Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to factors such as growing population, rising disposable income and improved healthcare infrastructure which are likely to boost product consumption in emerging countries such as China and India.
Growth Factors:
- Increasing demand for high-quality and nutritious food products is expected to drive the growth of the feed nucleotides market.
- Rising awareness about the benefits of feed nucleotides is projected to boost the demand for these products over the next few years.
- Growing adoption of precision farming techniques is anticipated to create new opportunities for the growth of this market in near future.
- Proliferation of livestock farms across emerging economies is predicted to fuel demand for feed nucleotides in coming years.
Scope Of The Report
Report Attributes
Report Details
Report Title
Feed Nucleotides Market Research Report
By Type
Yeast/Yeast Extracts, Single Cell Organisms, Others
By Application
Immune Enhancers, Dietary Supplements, Others
By Companies
Adisseo France SAS (France), Ajinomoto Co., Inc. (Japan), Leiber GmbH (Germany), Lesaffre Group (France), Archer Daniels Midland Company (USA), BASF SE (Germany), Biovet JSC (Bulgaria), Cargill, Inc. (USA), Chr. Hansen A/S (Denmark), Lonza Ltd. (Switzerland), Danisco A/S (Denmark), Elanco (USA), Evonik Degussa GmbH (Germany), Kemin Industries, Inc. (USA)
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
248
Number of Tables & Figures
174
Customization Available
Yes, the report can be customized as per your need.
Global Feed Nucleotides Market Report Segments:
The global Feed Nucleotides market is segmented on the basis of:
Types
Yeast/Yeast Extracts, Single Cell Organisms, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Immune Enhancers, Dietary Supplements, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Adisseo France SAS (France)
- Ajinomoto Co., Inc. (Japan)
- Leiber GmbH (Germany)
- Lesaffre Group (France)
- Archer Daniels Midland Company (USA)
- BASF SE (Germany)
- Biovet JSC (Bulgaria)
- Cargill, Inc. (USA)
- Chr. Hansen A/S (Denmark)
- Lonza Ltd. (Switzerland)
- Danisco A/S (Denmark)
- Elanco (USA)
- Evonik Degussa GmbH (Germany)
- Kemin Industries, Inc. (USA)
Highlights of The Feed Nucleotides Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Yeast/Yeast Extracts
- Single Cell Organisms
- Others
- By Application:
- Immune Enhancers
- Dietary Supplements
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Feed Nucleotides Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Feed Nucleotides is a company that provides nucleotide supplements to livestock. The company sells products such as nucleotide concentrates, premixes, and feed additives.
Some of the key players operating in the feed nucleotides market are Adisseo France SAS (France), Ajinomoto Co., Inc. (Japan), Leiber GmbH (Germany), Lesaffre Group (France), Archer Daniels Midland Company (USA), BASF SE (Germany), Biovet JSC (Bulgaria), Cargill, Inc. (USA), Chr. Hansen A/S (Denmark), Lonza Ltd. (Switzerland), Danisco A/S (Denmark), Elanco (USA), Evonik Degussa GmbH (Germany), Kemin Industries, Inc. (USA).
The feed nucleotides market is expected to register a CAGR of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Feed Nucleotides Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Feed Nucleotides Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Feed Nucleotides Market - Supply Chain
4.5. Global Feed Nucleotides Market Forecast
4.5.1. Feed Nucleotides Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Feed Nucleotides Market Size (000 Units) and Y-o-Y Growth
4.5.3. Feed Nucleotides Market Absolute $ Opportunity
5. Global Feed Nucleotides Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Feed Nucleotides Market Size and Volume Forecast by Type
5.3.1. Yeast/Yeast Extracts
5.3.2. Single Cell Organisms
5.3.3. Others
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Feed Nucleotides Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Feed Nucleotides Market Size and Volume Forecast by Application
6.3.1. Immune Enhancers
6.3.2. Dietary Supplements
6.3.3. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Feed Nucleotides Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Feed Nucleotides Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Feed Nucleotides Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Feed Nucleotides Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Feed Nucleotides Demand Share Forecast, 2019-2026
9. North America Feed Nucleotides Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Feed Nucleotides Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Feed Nucleotides Market Size and Volume Forecast by Application
9.4.1. Immune Enhancers
9.4.2. Dietary Supplements
9.4.3. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Feed Nucleotides Market Size and Volume Forecast by Type
9.7.1. Yeast/Yeast Extracts
9.7.2. Single Cell Organisms
9.7.3. Others
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Feed Nucleotides Demand Share Forecast, 2019-2026
10. Latin America Feed Nucleotides Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Feed Nucleotides Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Feed Nucleotides Market Size and Volume Forecast by Application
10.4.1. Immune Enhancers
10.4.2. Dietary Supplements
10.4.3. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Feed Nucleotides Market Size and Volume Forecast by Type
10.7.1. Yeast/Yeast Extracts
10.7.2. Single Cell Organisms
10.7.3. Others
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Feed Nucleotides Demand Share Forecast, 2019-2026
11. Europe Feed Nucleotides Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Feed Nucleotides Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Feed Nucleotides Market Size and Volume Forecast by Application
11.4.1. Immune Enhancers
11.4.2. Dietary Supplements
11.4.3. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Feed Nucleotides Market Size and Volume Forecast by Type
11.7.1. Yeast/Yeast Extracts
11.7.2. Single Cell Organisms
11.7.3. Others
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Feed Nucleotides Demand Share, 2019-2026
12. Asia Pacific Feed Nucleotides Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Feed Nucleotides Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Feed Nucleotides Market Size and Volume Forecast by Application
12.4.1. Immune Enhancers
12.4.2. Dietary Supplements
12.4.3. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Feed Nucleotides Market Size and Volume Forecast by Type
12.7.1. Yeast/Yeast Extracts
12.7.2. Single Cell Organisms
12.7.3. Others
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Feed Nucleotides Demand Share, 2019-2026
13. Middle East & Africa Feed Nucleotides Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Feed Nucleotides Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Feed Nucleotides Market Size and Volume Forecast by Application
13.4.1. Immune Enhancers
13.4.2. Dietary Supplements
13.4.3. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Feed Nucleotides Market Size and Volume Forecast by Type
13.7.1. Yeast/Yeast Extracts
13.7.2. Single Cell Organisms
13.7.3. Others
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Feed Nucleotides Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Feed Nucleotides Market: Market Share Analysis
14.2. Feed Nucleotides Distributors and Customers
14.3. Feed Nucleotides Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Adisseo France SAS (France)
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Ajinomoto Co., Inc. (Japan)
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Leiber GmbH (Germany)
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Lesaffre Group (France)
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Archer Daniels Midland Company (USA)
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. BASF SE (Germany)
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Biovet JSC (Bulgaria)
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Cargill, Inc. (USA)
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Chr. Hansen A/S (Denmark)
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Lonza Ltd. (Switzerland)
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Danisco A/S (Denmark)
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Elanco (USA)
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. Evonik Degussa GmbH (Germany)
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. Kemin Industries, Inc. (USA)
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
